BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8756377)

  • 1. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma.
    Yokogi H
    Cancer; 1996 Aug; 78(4):819-26. PubMed ID: 8756377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior.
    Appley AJ; Fitzgibbons PL; Chandrasoma PT; Hinton DR; Apuzzo ML
    Neurosurgery; 1990 Jul; 27(1):83-96. PubMed ID: 2377285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
    Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
    Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma].
    Tamaki M; Maeda S; Deguchi T; Kawada Y
    Hinyokika Kiyo; 1997 Oct; 43(10):697-702. PubMed ID: 9395903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index.
    Grignon DJ; Abdel-Malak M; Mertens W; Koster J; Keeney M; Sakr W; Shepherd RR
    Mod Pathol; 1995 Jan; 8(1):18-24. PubMed ID: 7731937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferating cell nuclear antigen expression as a prognostic indicator for renal cell carcinoma: comparison with pathologic features and DNA content].
    Nakano S; Kawamura J
    Hinyokika Kiyo; 1995 May; 41(5):343-8. PubMed ID: 7598033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
    Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
    Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
    Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of DNA-aneuploidy subgroups and proliferation in renal cell carcinoma.
    Schafhauser W; Liedl T; Elsässer D; Zörcher T; Schrott KM
    Anticancer Res; 1999; 19(2C):1471-5. PubMed ID: 10365126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.
    Mise K; Tashiro S; Yogita S; Wada D; Harada M; Fukuda Y; Miyake H; Isikawa M; Izumi K; Sano N
    Clin Cancer Res; 1998 Jun; 4(6):1475-82. PubMed ID: 9626465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas.
    Turner RR; Layfield LJ; Bishop PC; Epstein AL; Parker JW
    Arch Pathol Lab Med; 1989 Aug; 113(8):907-11. PubMed ID: 2569301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in advanced gastric cancers.
    Kimura H; Yonemura Y; Epstein AL
    Cancer; 1991 Nov; 68(10):2175-80. PubMed ID: 1913456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
    Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O
    J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: its correlation with histopathology and prognosis.
    Yu DS; Hsu CM; Lee WH; Chang SY; Ma CP
    J Surg Res; 1993 Nov; 55(5):480-5. PubMed ID: 8231166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.